MENU
ENTA
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Enanta Pharmaceuticals (ENTA) Ownership - Who owns Enanta Pharmaceuticals?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
500 Arsenal Street
Phone
+1 617 607-0800
Employees
145
Web
https://www.enanta.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
212.95M
P/E Ratio
N/A
Total Cash
230.09M
Projected Growth
N/A
Total Debt
50.57M
Revenue
71.96M
Risk (Beta)
0.93
Dividend Yield
N/A
Total Cash/Share
10.86
Total Debt/Equity
N/A
Revenue/Share
3.41 USD as % of share price
Fundamentals
ENTA
Capitalization
213M
P/E Ratio
N/A
Risk (Beta)
0.93
Dividend Yield
N/A
Total Cash
230M
Total Cash/Share
10.86
Total Debt
50.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.41%
Revenue
72M
ROE
N/A
Book Value
149M
P/B Ratio
1.47
Cash Flow
N/A
Earnings
-5.45
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
212K
Current Ratio
4.92
Current Revenue Per Employee
123937.93
Dividends Per Share - Security
N/A
EBITDA
-104.08M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-25.80
Shares Held By Institutions
742M
Shares Outstanding - Current
21.2M
Total Liabilities
250M
Total Volume MTD
N/A
Value
-1
Gain YTD
28.587
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drugs and other pharmaceuticals products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Arsenal Street
Phone
+1 617 607-0800
Employees
145
Web
https://www.enanta.com